Poly Medicure Ltd. Conference Calls and Earnings Call Transcripts

Poly Medicure Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submit Transcript of the Investor Meet/Call held on 02nd February, 2024 at 04:00 P.M(IST) on the Unaudited Financial Results of the Company for the quarter ended 31st December, 2023 on Standalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 31st January, 2024.
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Friday, February 02, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended December 31, 2023 , is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/02/ICI3420240202151273.mp3
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, 2nd February, 2024 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 31st December, 2023. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby submit transcript of the Investot Meet/Call held on 6th November, 2023, on the Unaudited Financial Results of the Company for the quarter and half year ended on 30th September, 2023, on standalone and consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 4th November, 2023.
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Monday, November 06, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended September 30, 2023.
2067.10
-8.49%
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Tuesday, August 08, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30, 2023, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2023/08/ICI3420230808148657.mp3.
2067.10
-8.49%
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Tuesday, August 08, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30, 2023, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2023/08/ICI3420230808148657.mp3.
2067.10
-8.49%
Conference Call with Poly Medicure Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
2067.10
-8.49%

Conference Call with Poly Medicure Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.

No results found

Earnings Calls Podcast on